Literature DB >> 20685758

Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci.

S Ledig1, O Hiort, G Scherer, M Hoffmann, G Wolff, S Morlot, A Kuechler, P Wieacker.   

Abstract

BACKGROUND: XY gonadal dysgenesis (XY-GD) is a heterogeneous disorder characterized by failure of testicular development despite a normal male karyotype. Non-syndromic and syndromic forms can be delineated. Currently, only a minority of cases can be explained by gene mutations.
METHODS: The aim of this study was to detect microdeletions and duplications by using high-resolution Agilent oligonucleotide arrays in a cohort of 87 patients with syndromic or non-syndromic 46,XY-GD.
RESULTS: In 26 patients, we identified gains or losses in regions including genes involved in XY-GD (DMRT1, SOX9, DAX1) or in regions, which have not been described as polymorphic copy number variants (CNVs).
CONCLUSIONS: This study shows that array comparative genomic hybridization (CGH) analysis is a useful tool for the molecular diagnosis of XY-GD as well as for the identification of potential candidate genes involved in male sexual development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685758     DOI: 10.1093/humrep/deq167

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  28 in total

Review 1.  Towards improved genetic diagnosis of human differences of sex development.

Authors:  Emmanuèle C Délot; Eric Vilain
Journal:  Nat Rev Genet       Date:  2021-06-03       Impact factor: 53.242

Review 2.  New technologies to uncover the molecular basis of disorders of sex development.

Authors:  Hayk Barseghyan; Emmanuèle C Délot; Eric Vilain
Journal:  Mol Cell Endocrinol       Date:  2018-04-13       Impact factor: 4.102

Review 3.  Disorders of sex development: effect of molecular diagnostics.

Authors:  John C Achermann; Sorahia Domenice; Tania A S S Bachega; Mirian Y Nishi; Berenice B Mendonca
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

4.  Gene dosage effects in 46, XY DSD: usefulness of CGH technologies for diagnosis.

Authors:  S Jaillard; A Bashamboo; L Pasquier; M A Belaud-Rotureau; K McElreavey; S Odent; Célia Ravel
Journal:  J Assist Reprod Genet       Date:  2014-11-12       Impact factor: 3.412

Review 5.  Expanding roles for the evolutionarily conserved Dmrt sex transcriptional regulators during embryogenesis.

Authors:  Eric J Bellefroid; Lucas Leclère; Amandine Saulnier; Marc Keruzore; Maria Sirakov; Michel Vervoort; Sarah De Clercq
Journal:  Cell Mol Life Sci       Date:  2013-03-05       Impact factor: 9.261

Review 6.  Management of disorders of sex development.

Authors:  Olaf Hiort; Wiebke Birnbaum; Louise Marshall; Lutz Wünsch; Ralf Werner; Tatjana Schröder; Ulla Döhnert; Paul-Martin Holterhus
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

7.  Sex and the circuitry: progress toward a systems-level understanding of vertebrate sex determination.

Authors:  Steven C Munger; Blanche Capel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-05-17

Review 8.  Genetics of Disorders of Sex Development: The DSD-TRN Experience.

Authors:  Emmanuèle C Délot; Jeanette C Papp; David E Sandberg; Eric Vilain
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-28       Impact factor: 4.741

9.  Rare double sex and mab-3-related transcription factor 1 regulatory variants in severe spermatogenic failure.

Authors:  A C Lima; F Carvalho; J Gonçalves; S Fernandes; P I Marques; M Sousa; A Barros; S Seixas; A Amorim; D F Conrad; A M Lopes
Journal:  Andrology       Date:  2015-07-02       Impact factor: 3.842

10.  Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.

Authors:  Steven M Harrison; Ian M Campbell; Melise Keays; Candace F Granberg; Carlos Villanueva; Grace Tannin; Andrew R Zinn; Diego H Castrillon; Chad A Shaw; Pawel Stankiewicz; Linda A Baker
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.